Satyamvada Maurya | Computational Biology | Best Researcher Award

Published-on by Indian Scientist

Mrs. Satyamvada Maurya | Computational Biology | Best Researcher Award

ICAR-National Bureau of Fish Genetic Resources | India

Dr. Satyamvada Maurya is a bioinformatics researcher with extensive experience in genomics, computational biology, and drug discovery. She holds a Ph.D. in Bioinformatics, focusing on the design and development of novel anti-tuberculosis agents through computational approaches. Her academic foundation includes a Master’s in Bioinformatics and a Bachelor’s in Biotechnology, which laid the groundwork for her multidisciplinary research. She has worked as a Project Assistant and Young Professional in premier Indian research institutes, contributing to projects in genome analysis, database development, SNP characterization, and functional genomics of aquatic organisms, particularly Clarias magur. Her research interests span next-generation sequencing, genome analysis, protein structure-function prediction, drug design, homology modeling, phylogenetic analysis, and database creation for biological resources. She has authored multiple research articles, book chapters, training manuals, and popular science articles, accumulating 27 citations with an h-index of 3 and i10-index of 1, reflecting the impact of her work. She has received awards including the TEQIP fellowship and best presentation accolades at national and international conferences. Dr. Maurya is committed to advancing bioinformatics applications in both healthcare and aquaculture, bridging computational tools with experimental biology to address complex biological challenges. Her work continues to contribute to the development of innovative solutions in genomics and drug discovery.

Profile: Google Scholar

Featured Publications

Verma, S., Maurya, R., & Maurya, S. (2016). Prediction of gene action and combining ability for yield and quality traits in F1 and F2 generations of wheat (Triticum aestivum L.). Tropical Plant Research, 3(2), 449–459.

Maurya, S., Jain, A., Singh, V., Haque, S., & Mishra, B. N. (2023). Evaluation of Saraca asoca for its anti-tubercular potential via molecular docking and molecular dynamics simulation studies. ChemistrySelect, 8(12), e202204899.

Maurya, S., Alhazmi, A., Vidyarthi, A. S., Jain, A., Singh, V., Khan, F., Haque, S., & Mishra, B. N. (2022). In-silico study reveals potential antitubercular drug targets unique to Mycobacterium tuberculosis H37Rv. Minerva Biotechnology & Biomolecular Research, 34(2), 71–79.

Maurya, S., Kumar, M. S., Kumar, R., & Kushwaha, B. (2024). Role of machine learning and artificial intelligence in transforming aquaculture and fisheries sector. Indian Farming, 74(8), 24–27.

Maurya, S., Jain, A., Rehman, M. T., Hakamy, A., Bantun, F., AlAjmi, M. F., Singh, V., … Mishra, B. N. (2023). In silico identification of novel derivatives of rifampicin targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin derivatives target VapC2 of Mtb H37Rv. Molecules, 28(4), 1652.

Anupam Kanti Bag | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Dr. Anupam Kanti Bag | Pharmacology | Best Researcher Award

Dr. B.C. Roy College of Pharmacy and Allied Health Sciences |India

Dr. Anupam Kanti Bag is an accomplished pharmacology professional with strong academic and research credentials, reflected through 142 citations, an h-index of 3, and 3 i10-index publications, demonstrating consistent scholarly impact. His expertise spans microscopy, molecular biology, behavioral analysis, molecular docking, and network pharmacology, supported by extensive laboratory experience and a solid background in pharmaceutical sciences. He has significantly contributed to innovation through multiple national and international patents in drug formulation, medical device design, and pharmacokinetic enhancement, along with authoring books and contributing chapters in emerging areas of neurodegenerative disease research. His funded research work includes projects focusing on phytochemical formulations and nano-based therapeutic applications. Dr. Bag has served in various academic, administrative, and accreditation roles, including NAAC/NBA coordination, placement operations, exam cell management, and institutional leadership responsibilities across reputed pharmacy colleges. His technical skills extend to tools such as Pyrex, Pymol, Chimera, and Biovia Studio, combined with proficiency in cell culture handling, gene assays, ADR reporting, and laboratory instrumentation. Recognized with awards for academic excellence, mentoring, and scientific presentations, he continues to contribute to the advancement of pharmacology research with dedication to innovation, collaboration, and student development.

Profile: Google Scholar

Featured Publications

Bag, A. K., & Mumtaz, S. M. F. (2013). Hepatoprotective and nephroprotective activity of hydroalcoholic extract of Ipomoea staphylina leaves. Bangladesh Journal of Pharmacology, 8(3), 263–268.

Subramaniyan, V., Shaik, S., Bag, A., Manavalan, G., & Chandiran, S. (2018). Potential action of Rumex vesicarius (L.) against potassium dichromate and gentamicin-induced nephrotoxicity in experimental rats. Pakistan Journal of Pharmaceutical Sciences, 31(2), 509–516.

Mumtaz, S. M. F., Paul, S., & Bag, A. K. (2013). Effect of Sechium edule on chemical-induced kidney damage in experimental animals. Bangladesh Journal of Pharmacology, 8(1), 28–35.

Bag, A. K., & Hiremath, S. R. R. (2023). Neuropathic pain and its management. Indian Journal of Pharmacy Practice, 16(3).

Verma, P., Munirangappa, H., Bag, A. K., & Purushottam, H. (2023). Amelioration of hyperglycemia by hydroalcoholic extract of leaves of Ecbolium viride against experimental type II model in rats.

Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Published-on by Indian Scientist

Mr. Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Chitkara University Punjab | India

Ankush Kumar is a dedicated pharmaceutical researcher whose work spans medicinal chemistry, molecular modeling, and targeted drug design with a strong focus on anticancer therapeutics. He holds a solid academic foundation with qualifications in pharmaceutical chemistry and extensive research training that includes computational drug design, structure-activity exploration, and medicinal insights into heterocyclic scaffolds. His professional experience includes serving as a Junior Research Fellow and working as an Assistant Professor across multiple academic institutions, where he contributed to teaching, mentoring, and research development. His research outputs reflect a strong contribution to oncology-oriented drug discovery, with publications covering molecular targets, biomarkers, EGFR inhibition, heterocyclic synthesis, and computational repurposing studies. He has authored numerous research papers in reputed journals, contributing to a total of 561 citations, supported by an h-index of 6 and i10-index of 4, demonstrating the growing influence of his scientific contributions. His work includes book chapters and multiple peer-reviewed articles that highlight new therapeutic strategies and structural insights into various biological targets. He has received academic distinctions such as top positions in academic competitions and has served as a reviewer for international journals, further reflecting his scholarly engagement. Overall, his research trajectory reflects a commitment to advancing pharmaceutical innovation and precision-driven drug discovery.

Profile: Google Scholar

Featured Publications

Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., Vishakha, Jha, S. K., et al. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer, 22(1), 105.

Kumar, A., Sehgal, A., Singh, S., Sharma, N., Yadav, S., Rashid, S., Ali, N., et al. (2023). Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer. International Journal of Biological Macromolecules, Article 126595.

Zheng, M., Kumar, A., Sharma, V., Sehgal, A., Wal, P., Shinde, N. V., Kawaduji, B. S., et al. (2024). Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. Frontiers in Cell and Developmental Biology, 12, Article 1353860.

Kumar, A., Kumar, B., & Bhatia, R. (2023). Design, synthesis, molecular docking, and biological evaluation of isatin-based fused heterocycles as epidermal growth factor receptor inhibitors. Assay and Drug Development Technologies, 21(5), 222–233.

Kumar, A., Narang, R. K., & Bhatia, R. (2023). Recent advancements in NS5B inhibitors (2011–2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure, 1293, Article 136272.